ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disparities"

  • Abstract Number: 0116 • ACR Convergence 2022

    Racial Differences in Medication Beliefs and Barriers to Taking Medications Among Patients with SLE

    Emilio Guzman Cisneros1, Shannon Herndon1, Theresa Coles2, Corrine Voils3, Megan Clowse4, Rebecca Sadun4, Jennifer Rogers5, Lisa Criscione-Schreiber2, Jayanth Doss4, Amanda Eudy6 and Kai Sun4, 1Duke University Hospital, Durham, NC, 2Duke University School of Medicine, Durham, NC, 3University of Wisconsin School of Medicine and Public Health, Madison, WI, 4Duke University, Durham, NC, 5Duke, Durham, NC, 6Duke University, Raleigh, NC

    Background/Purpose: Medication adherence is critical for SLE management and can be influenced by patients' barriers and beliefs about treatment. Patients of color with SLE have…
  • Abstract Number: 1099 • ACR Convergence 2022

    Empowering Patients with Lupus Through Their Photographs: Application of the Photovoice Method to Understand Social Determinants of Health

    Sciaska Ulysse1, Kreager Taber2, Jessica Williams3, Laura Lorenz4 and Candace Feldman1, 1Brigham and Women's Hospital, Boston, MA, 2Duke University, Durham, NC, 3Emory University School of Medicine, Atlanta, GA, 4Brandeis University, Waltham, MA

    Background/Purpose: Photovoice is a participatory visual research method that provides individuals with cameras and empowers them to share aspects of their daily lives and environments…
  • Abstract Number: 0093 • ACR Convergence 2022

    Comparison of Faculty and Fellow Prescribing Patterns for Rheumatoid Arthritis in an Urban, Academic Hospital

    Ana Valle1, Xianhong Xie2, Don-Andre Jackson3 and Irene Blanco4, 1Montefiore Medical Center, New York, NY, 2Department of Epidemiology & Population Health/Albert Einstein College of Medicine, Bronx, NY, 3Griffin Health, Stamford, CT, 4Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: Timely initiation of DMARDs in rheumatoid arthritis (RA) is necessary to prevent significant morbidity and mortality. Yet, patients from marginalized groups are less likely…
  • Abstract Number: 0117 • ACR Convergence 2022

    Disparities in Prescription Medications Among Myositis Patients in a Large Urban Medical Center

    Diala Alawneh1, Zita Chan1, William Galanter2, John Berry3, Mina Al-Awqati4 and Huan Chang5, 1University of Illinois at Chicago, Chicago, IL, 2University of Chicago, Chicago, IL, 3University of Illinois Hospital & Health Sciences System, Chicago, IL, 4University of Illinois, Chicago, IL, 5University of Illinois at Chicago and Jesse Brown VA Medical Center, Chicago, IL

    Background/Purpose: Although women are twice as likely as men to develop myositis, Black women are affected disproportionately. Additionally, minorities with juvenile dermatomyositis are significantly more…
  • Abstract Number: 1100 • ACR Convergence 2022

    Racial Differences in Clinical Trial Perceptions Among a Large, Predominantly Black Cohort of Patients with Systemic Lupus Erythematosus in the Southeastern United States

    Jessica Williams1, Gaobin Bao1, Charmayne Dunlop-Thomas2, Cristina Drenkard2, Kim Schofield1 and S. Sam Lim2, 1Emory University School of Medicine, Atlanta, GA, 2Emory University, Atlanta, GA

    Background/Purpose: Black patients have higher incidence and severity of systemic lupus erythematosus (SLE) and worse outcomes as compared to White patients, yet Black patients are…
  • Abstract Number: 0095 • ACR Convergence 2022

    Association of Urban vs. Rural Residence with New DMARD Initiation in US Veterans with Active Rheumatoid Arthritis

    Luke Desilet1, Harlan Sayles1, Punyasha Roul2, Jennifer Barton3, Gail Kerr4, Kaleb Michaud1, Ted Mikuls5 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2UNMC, Omaha, NE, 3VA Portland Health Care System/OHSU, Portland, OR, 4Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 5Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: While a treat-to-target strategy is endorsed by the ACR RA Treatment Guidelines, many patient, social, and healthcare system factors make implementation of this approach…
  • Abstract Number: 0118 • ACR Convergence 2022

    Sex-Based Variations in Emergency Department Utilization by Persons with Inflammatory Arthritis Conditions

    Cheryl Barnabe1, Patrick McLane2, Nadia Luca1, Katie Lin1, Kelsey Chomistek1, Meghan Elliott1, Shanon McQuitty3, Eileen Davidson3, Clare Hildebrandt4, Steven Katz2, Brian Holroyd2 and Claire Barber1, 1University of Calgary, Calgary, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Patient and Family Advisors, Alberta Health Services, Calgary, AB, Canada

    Background/Purpose: High quality ambulatory care provision should mitigate avoidable emergency department (ED) visits by persons with inflammatory arthritis (IA) conditions and address the unique realities…
  • Abstract Number: 1306 • ACR Convergence 2022

    Improving Osteoporosis Screening in Individuals of Color

    Megan Brochu1, Kristofer Marcus1, Sarah Latorre1, Francis Wanjau1, Arvin Garg2, Eric Alper2, Rulan Lyu1, Tracey Wilkie1 and Jonathan Cheah3, 1UMass Memorial Health, Worcester, MA, 2UMass Memorial Health, UMass Chan Medical School, Worcester, MA, 3UMass Chan Medical School, Worcester, MA

    Background/Purpose: Osteoporosis, including the clinical event of fragility fracture is an ever-increasing public health burden. Effective screening techniques and well as therapies to reduce future…
  • Abstract Number: 0096 • ACR Convergence 2022

    Delayed Referral of Female Rheumatoid Arthritis Patients: Where Are We Now? A Study Spanning Three Decades

    Bastiaan van Dijk1 and Annette van der Helm-van Mil2, 1Leiden University Medical Centre (LUMC), Leiden, Netherlands, 2Leiden University Medical Center, Erasmus Medical Center, Leiden, Netherlands

    Background/Purpose: Delayed referral of female RA-patients was reported twenty years ago: the time between the first appointment with the general practitioner (GP) and referral to…
  • Abstract Number: 0122 • ACR Convergence 2022

    Documentation of Social Determinants of Health Among Individuals with Systemic Rheumatic and Musculoskeletal Diseases

    Sciaska Ulysse, Mia Chandler, Leah Santacroce, Tianrun Cai, Katherine Liao and Candace Feldman, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Social determinants of health (SDoH), "the conditions in which people are born, grow, work, live, and age" (World Health Organization, 2022), directly influence health…
  • Abstract Number: 1383 • ACR Convergence 2022

    Differences in Clinical and Patient-reported Outcomes in Juvenile Dermatomyositis by Race and Ethnicity

    Rebecca Olveda, Jessica Neely and Susan Kim, UCSF Benioff Children's Hospital, San Francisco, CA

    Background/Purpose: Previous studies in juvenile dermatomyositis (JDM) have shown that patients from minoritized ethnicities and those with lower family income are more likely to have…
  • Abstract Number: 0098 • ACR Convergence 2022

    Delays in Access to Specialized Care and Diagnosis in Patients with Systemic Lupus Erythematosus

    Alain Sanchez-Rodriguez1, Jose A Meade-Aguilar2, Jeffrey X. Yang2, Gabriel Figueroa Parra2, Shirley-Ann Osei-Onomah2, Rachel Giblon3, Hannah Langenfeld4, Alanna Chamberlain2, Cynthia Crowson5 and Ali Duarte-Garcia2, 1Division of Rheumatology, Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic, Rochester, MN, Rochester, MN, 4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, 5Mayo Clinic, Eyota, MN

    Background/Purpose: Delays in access to specialized care and diagnosis of systemic lupus erythematosus (SLE) are associated with poor outcomes. Prior studies rely mostly on cross-sectional…
  • Abstract Number: 0186 • ACR Convergence 2022

    Evaluating the Effectiveness & Impact of an In-Person Peer Support Group That Transitioned to a Virtual Platform During the COVID-19 Pandemic

    Giselle Rodriguez1, Priscilla Calvache1, Lillian Mendez1, Kimberly Cabrera1, Roberta Horton1, Lisa Imundo2 and Jillian Rose-Smith1, 1Hospital for Special Surgery, New York, NY, 2New York Presbyterian Hospital - Columbia Campus, New York, NY

    Background/Purpose: Studies have demonstrated the benefits of online peer support forums in meeting the mental health, disease self-management & coping needs of people living with…
  • Abstract Number: 1469 • ACR Convergence 2022

    Risk Factors for Herpes Zoster Among Patients with Systemic Lupus Erythematosus

    Caroline Spitznagel, Fedelis Mutiso, Jim Oates and Diane Kamen, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) have a higher prevalence and incidence of herpes zoster (HZ) compared with the general population. Our study was…
  • Abstract Number: 0099 • ACR Convergence 2022

    Impact of Multimodal Independent Medical Education on Improving Outcomes and Reducing Disparities in Systemic Lupus Erythematosus and Lupus Nephritis

    Lisa Handley1, Kimberly Lovin Nealy2 and Sarah A. Nisly3, 1Clinical Care Options, Clive, IA, 2Clinical Care Options, Matthews, NC, 3Clinical Care Options, Reston, VA

    Background/Purpose: Due to its range of manifestations and lack of specific findings, early diagnosis of SLE is often a challenge, and serious complications, including LN,…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 22
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology